Omnia Wellness (OMWS) 10-Q 28 Nov 22 2023 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Sep. 30, 2022	Nov. 28, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2022
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--03-31
Entity File Number	333-211986
Entity Registrant Name	OMNIA WELLNESS INC
Entity Central Index Key	0001676852
Entity Tax Identification Number	98-1291924
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	999 18th Street
Entity Address, Address Line Two	Suite 3000
Entity Address, City or Town	Denver
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80202
City Area Code	(888)
Local Phone Number	320-5711
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		231,505,146

Consolidated Balance Sheet (Una

Consolidated Balance Sheet (Unaudited) - USD ($)	Sep. 30, 2022	Mar. 31, 2022
Current assets:
Cash		$ 1,894
Accounts receivable	54,251	118,349
Due from related parties	89,505	91,380
Inventory	24,000	24,000
Total current assets	167,756	235,623
Non-current assets:
Fixed assets, net	501,778	515,113
Intangible assets, net	1,350,850	1,450,900
ROU assets, net	117,098	160,197
Total non-current assets	1,969,726	2,126,210
Total assets	2,137,482	2,361,833
Current liabilities:
Accounts payable and accrued liabilities	981,301	562,213
Deposit liability		8,002
Accrued interest	893,443	615,261
Lease liability	101,465	99,464
Warranty liability	25,667	25,667
Royalty liability	155,289	143,817
Nonconvertible notes, related party	1,852,735	1,102,735
Nonconvertible notes	1,792,566	1,765,219
Convertible notes, related party	29,970	29,970
Convertible notes	1,368,193	1,229,443
Senior secured notes	675,000
Total current liabilities	7,875,629	5,581,791
Non-current liabilities:
Advances due to related party	163,239	143,239
Lease liability	33,997	80,099
Senior secured notes		675,000
Nonconvertible notes, related party	141,920	891,920
Nonconvertible notes	166,571	189,918
Convertible notes	70,000
Total non-current liabilities	575,727	1,980,176
Total liabilities	8,451,356	7,561,967
Stockholders’ deficit:
Stock Payable	230,367	642,867
Stock Reserve	412,500
Preferred stock; 150,000,000 shares authorized; no shares issued or outstanding
Common stock; $0.001 par value, 1,500,000,000 shares authorized; 231,505,146 and 232,222,818 issued and outstanding, respectively	231,505	232,223
Common Stock Subscribed $.001 par value subscribed common shares, 2,500,000 and -0- shares outstanding, respectively	2,500	2,500
Additional paid-in capital	5,445,438	5,344,318
Accumulated deficit	(12,226,184)	(11,012,042)
Stock Purchase Agreement Receivable	(410,000)	(410,000)
Total stockholders’ deficit	(6,313,874)	(5,200,134)
Total liabilities and stockholders’ deficit	$ 2,137,482	$ 2,361,833

Consolidated Balance Sheet (U_2

Consolidated Balance Sheet (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2022	Mar. 31, 2022
Statement of Financial Position [Abstract]
Preferred stock, shares authorized	150,000,000	150,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	1,500,000,000	1,500,000,000
Common stock, shares issued	231,505,146	232,222,818
Common stock, shares outstanding	231,505,146	232,222,818
Common stock subscribed, par value	$ 0.001	$ 0.001
Common stock subscribed, shares outstanding	2,500,000	0

Statements of Operations (Unaud

Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenue
Total revenue	$ 28,446	$ 57,809	$ 162,092	$ 94,931
Cost of goods sold
Cost of goods sold	77,534	8,477	98,500	15,010
Total cost of goods sold	77,534	8,477	98,500	15,010
Gross Profit	(49,088)	49,332	63,592	79,921
Operating expenses:
Warranty expense
Depreciation and amortization	95,448	72,557	190,783	143,036
Bad Debt Expense	6,000		6,000
Legal and professional fees	83,780	255,048	85,559	356,002
Payroll expense	88,230	58,937	219,501	84,104
Selling and marketing expense	2,220	30,544	20,779	30,920
Selling and marketing expense, related party
Consulting	27,239		44,180
Consulting, related party	45,000		91,000
Royalty expense	(3,805)		11,472
License royalties
General and administrative	64,776	9,184	150,096	68,412
Research and development		397,500	48,200	732,000
Total operating expenses	408,889	823,770	867,570	1,414,474
Other (income) expense:
Gain on PPP loan forgiven		(146,959)		(443,873)
Loss on debt settlement
Interest expense and finance costs	176,640	918,807	410,164	1,045,638
Total other (income) expense	176,640	771,848	410,164	601,765
Net loss	$ (634,617)	$ (1,546,286)	$ (1,214,142)	$ (1,936,318)
Net loss per common share – basic and diluted	$ 0	$ (0.01)	$ (0.01)	$ (0.01)
Weighted average common	231,509,068	224,213,846	231,507,112	224,213,846
Sales Net [Member]
Revenue
Total revenue	$ 28,446	$ 57,809	$ 162,092	$ 94,931

Statements of Changes in Stockh

Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)	Common Stock [Member]	Common Stock Subscribed [Member]	Preferred Stock [Member]	Stock Payable [Member]	Stock Reserve [Member]	Stock Purchase Agreement Receivables [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Mar. 31, 2021	$ 14,900						$ 2,065,923	$ (5,489,464)	$ (3,408,641)
Beginning balance, shares at Mar. 31, 2021	224,227,107
Additional paid in capital							430,123		430,123
Net Income (loss)								(390,032)	(390,032)
Ending balance, value at Jun. 30, 2021	$ 14,900						2,496,046	(5,879,496)	(3,368,550)
Ending balance, shares at Jun. 30, 2021	224,227,107
Beginning balance, value at Mar. 31, 2021	$ 14,900						2,065,923	(5,489,464)	(3,408,641)
Beginning balance, shares at Mar. 31, 2021	224,227,107
Net Income (loss)									(1,936,318)
Ending balance, value at Sep. 30, 2021	$ 14,900						3,250,337	(7,425,782)	(4,160,545)
Ending balance, shares at Sep. 30, 2021	224,227,107
Beginning balance, value at Jun. 30, 2021	$ 14,900						2,496,046	(5,879,496)	(3,368,550)
Beginning balance, shares at Jun. 30, 2021	224,227,107
Additional paid in capital							754,291		754,291
Net Income (loss)								(1,546,286)	(1,546,286)
Ending balance, value at Sep. 30, 2021	$ 14,900						3,250,337	(7,425,782)	(4,160,545)
Ending balance, shares at Sep. 30, 2021	224,227,107
Beginning balance, value at Mar. 31, 2022	$ 232,223	2,500		642,867		(410,000)	5,344,318	(11,012,042)	(5,200,134)
Beginning balance, shares at Mar. 31, 2022	232,222,818
Net Income (loss)								(579,526)	(579,526)
Reclass stock payable to Stock Reserve				(412,500)	412,500
Reclass par value of shares and shares outstanding	$ (718)						718
Reclass par value of shares and shares outstanding, shares	(717,672)
Beneficial conversion feature on convertible notes							77,561		77,561
Ending balance, value at Jun. 30, 2022	$ 231,505	2,500		230,367	412,500	(410,000)	5,422,597	(11,591,568)	(5,702,099)
Ending balance, shares at Jun. 30, 2022	231,505,146
Beginning balance, value at Mar. 31, 2022	$ 232,223	2,500		642,867		(410,000)	5,344,318	(11,012,042)	(5,200,134)
Beginning balance, shares at Mar. 31, 2022	232,222,818
Net Income (loss)									(1,214,142)
Ending balance, value at Sep. 30, 2022	$ 231,505	2,500		230,367	412,500	(410,000)	5,445,438	(12,226,184)	(6,313,874)
Ending balance, shares at Sep. 30, 2022	231,505,146
Beginning balance, value at Jun. 30, 2022	$ 231,505	2,500		230,367	412,500	(410,000)	5,422,597	(11,591,568)	(5,702,099)
Beginning balance, shares at Jun. 30, 2022	231,505,146
Net Income (loss)								(634,617)	(634,617)
Beneficial conversion feature on convertible notes							22,841		22,841
Ending balance, value at Sep. 30, 2022	$ 231,505	$ 2,500		$ 230,367	$ 412,500	$ (410,000)	$ 5,445,438	$ (12,226,184)	$ (6,313,874)
Ending balance, shares at Sep. 30, 2022	231,505,146

Statements of Cash Flows (Unaud

Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net loss	$ (1,214,142)	$ (1,936,318)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	147,685	143,576
BCF on convertible notes	100,402	771,576
Loss on debt settlement
Stock based compensation
Amortization of ROU asset	43,099
Amortization of warrants
Discount on notes
Royalty on sales	11,472
Finance costs related to note payable
Finance costs paid in stock
Gain on PPP loan forgiven		(440,266)
Rent payments on lease liability	(44,101)
Bad debt expense
Change in:
Accounts receivables, net	64,098	(72,418)
Due from related parties	1,875
Inventory		(24,000)
Deposits	(8,002)
Advance payments on purchase of inventory, related party
Accounts payable and accrued liabilities	449,088	7,771
Interest payable	278,182	13,401
Net cash used - operating activities	(170,344)	(1,536,678)
Cash flows from investing activities:
Purchase of fixed assets	(34,300)	(146,750)
Payments on license agreement, related party
Net cash used – investing activities	(34,300)	(146,750)
Cash flows from financing activities:
Subscriptions receivable
Proceeds from advances	20,000
Proceeds from loans payable	212,750	1,309,154
Payments on loans payable
Payments on advances	(30,000)
decrease in Stock subscription payable	(412,500)
Increase in Stock Reserve	412,500
Change in shareholders’ equity, net	718
Change in common stock	(718)	412,839
Net cash provided - financing activities	202,750	1,721,993
Net increase (decrease) in cash	(1,894)	38,565
Cash - beginning of year	1,894	28,761
Cash - end of year	$ 0	$ 67,326

Nature of Operations

Nature of Operations	6 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations	Note 1 Nature of Operations Omnia Wellness Inc. (the “Company”) was incorporated as a Nevada corporation on March 2, 2016 Nevada On June 25, 2019, Maksim Charniak, the Company’s then sole executive officer and director and the owner of 3,000,000 95.6 On March 5, 2020, the Company filed Amended and Restated Articles of Incorporation with the Secretary of State of the State of Nevada to, among other things, (i) increase the Company’s authorized shares of common stock from 75,000,000 100,000,000 10,000,000 12.6374:1 On April 17, 2020, the Company entered into a Share Exchange and Reorganization Agreement (the “Exchange Agreement”) with Omnia Wellness Corporation (formerly known as Bed Therapies Inc.), a Texas corporation (“Omnia Corp.”), and the beneficial stockholders of Omnia Corp. to acquire 100 0.001 Accordingly, the Company acquired 100% of Omnia Corp. in exchange for the issuance of 10,000,000 (not adjusted to reflect the Company’s 15:1 forward stock split on April 6, 2021) shares of the Company’s common stock and Omnia Corp. became the Company’s wholly owned subsidiary. As of the closing of the Acquisition (the “Closing”), Mr. Samad, resigned as an officer and director of the Company and agreed to cancel 52,656,888 1,269,665 539,000 As of immediately prior to the closing of the Acquisition, the Company entered into an Assignment and Assumption Agreement with RZI Consulting LLC (the “Assignment Agreement”), pursuant to which RZI Consulting LLC assumed substantially all of the Company’s remaining assets and liabilities through the closing of the Acquisition. Accordingly, as of the closing of the Acquisition, the Company had no assets or liabilities (other than relating to general and administrative expenses). Following the Acquisition, the Company, through its wholly owned subsidiary Omnia Corp., now develops and markets products for wellness and physical therapy markets, using patented dry-hydro therapy equipment that the Company plans to offer and sell in medical and fitness markets. On April 6, 2021, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to (i) increase the Company’s authorized shares of common stock from 100,000,000 1,500,000,000 10,000,000 150,000,000 The Company’s principal executive office is located at 999 18 th In March 2020 the World Health Organization declared COVID-19 a pandemic. The Company is still assessing the impact COVID-19 may have on its business, but there can be no assurance that this analysis will enable the Company to avoid part or all of any impact from the spread of COVID-19 or its consequences, including downturns in business sentiment generally. The extent to which the COVID-19 pandemic and global efforts to contain its spread will impact the Company’s operations will depend on future developments, which are highly uncertain and cannot be predicted at this time, and include the duration, severity and scope of the pandemic and the actions taken to contain or treat the COVID-19 pandemic.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 Summary of Significant Accounting Policies The principal accounting policies applied in the preparation of these financial statements are set out below. Basis of Presentation Principles of Consolidation Unaudited Interim Financial Information - The accompanying Consolidated Balance Sheet as of September 30, 2022 and 2021, the Consolidated Statements of Income for the three and six months ended September 30, 2022 and 2021, the Consolidated Statements of Changes in Stockholders Equity for the six months ended September 30, 2022 and 2021, and the Consolidated Statements of Cash Flows for the six month ended September 30, 2022 and 2021 are unaudited. These unaudited interim consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP). In our opinion, the unaudited interim consolidated financial statements include all adjustments of a normal recurring nature necessary for the fair presentation of our financial position as of September 30, 2022 and 2021, our results of operations for the three and six months ended September 30, 2022 and 2021, and our cash flows for the six months ended September 30, 2022 and 2021. The results of operations for the three and six months ended September 30, 2022 and 2021 are not necessarily indicative of the results to be expected for the year ending March 31, 2023. These unaudited interim consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2022 filed with the SEC on October 17, 2022. Prior period balance related to inventories has been reclassified to conform to the current year presentation. Accounting Estimates Risks and Uncertainties Loss Per Common Share 231,505,146 224,227,107 Cash Accounts Receivable 54,251 66,950 Related Party Transactions Advance Payments on Purchases of Inventory, related party 0 40,000 Fixed Assets 241,854 169,230 Intangible Asset 10 650,150 500,075 Leases License Payable, related party Warranty Liability 5 Beneficial Conversion Features Derivatives Revenue The Company derives its revenues primarily from the usage fees and sales of hydrotherapy massage beds and installation services. Revenues from sales are recognized when the products are sold and delivered to its customers and the usage fees are earned based on subscription or actual usage. Sales Taxes and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. Shipping and handling fees charged to customers are reported within revenue. Income Taxes The Company adopted section 740-10-25 of the FASB Accounting Standards Codification (“Section 740-10-25”). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Section 740-10-25 also provides guidance on de- recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carrybacks and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary. Management makes judgments as to the interpretation of the tax laws that might be challenged upon an audit and cause changes to previous estimates of tax liability. In addition, the Company operates within multiple taxing jurisdictions and is subject to audit in these jurisdictions. In management’s opinion, adequate provisions for income taxes have been made for all years. If actual taxable income by tax jurisdiction varies from estimates, additional allowances or reversals of reserves may be necessary. Fair Value of Financial Instruments Fair Value Measurements and Disclosures ● Level 1: Quoted prices for identical assets and liabilities in active markets; ● Level 2: Quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and ● Level 3: Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The carrying amounts of financial instruments including cash, accounts payable, warranty liability and notes payable approximated fair value based on Level 1 measurement as of September 30, and 2021 due to the relatively short maturity of the respective instruments. Recently Issued Accounting Pronouncements - In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments Implementation of this ASU had no material impact on the consolidated financial statements. In August 2020, the FASB issued ASU 2020-06 , Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity Derivatives and Hedging Derivatives and Hedging—Contracts in Entity’s Own Equity As of September 30, 2022, there were several new accounting pronouncements issued by the Financial Accounting Standards Board. Each of these pronouncements, as applicable, has been or will be adopted by the Company. Management does not believe the adoption of any of these accounting pronouncements has had or will have a material impact on the Company’s consolidated financial statements.

Going Concern

Going Concern	6 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	Note 3 Going Concern The Company adopted Accounting Standards Update No. 2014-15, “Presentation of Financial Statements-Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”) The Company is commencing operations to generate sufficient revenue; however, the Company’s cash position may not be sufficient to support the Company’s daily operations. Management intends to raise additional funds by way of a private or public offering. While the Company believes in the viability of its strategy to commence operations and generate sufficient revenue and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate sufficient revenue and its ability to raise additional funds by way of private offering. The financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

Related Parties

Related Parties	6 Months Ended
	Sep. 30, 2022
Related Party Transactions [Abstract]
Related Parties	Note 4 Related Parties The Company outsources its manufacturing pursuant to a Contract Services Agreement with DryRX, LLC dated as of January 1, 2020, which replaced and superseded the Contract Services Agreement with DryRX, LLC dated as of July 22, 2018, which expired in accordance with its terms. The Contract Services Agreement, among other things, provides that DryRX shall provide manufacturing and support services on behalf of the Company, and shall be responsible for the manufacturing oversight and production operations of the Company’s products. In return, the Company is obligated to pay to DryRX a fee equal to 10 122,481 The Company entered into a Consulting Agreement with Massagewave, Inc., owned and controlled by Steve Howe, to assist with business development and administrative activities. The agreement was entered into on May 1, 2018 and had required monthly payments of $ 15,000 April 30, 2020 April 30, 2023 91,000 0

Fixed Assets

Fixed Assets	6 Months Ended
	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Fixed Assets	Note 5 Fixed Assets The carrying basis and accumulated depreciation of fixed assets at September 30, 2022 and 2021 is as follows: Schedule of Fixed Assets Useful Lives September 30, 2022 September 30, 2021 Equipment in use 5 $ 394,620 $ 359,000 Vehicles and Trailers 5 60,266 60,266 Patent Costs 10 2,001,000 2,001,000 Building improvements 40 288,746 167,565 Less depreciation and amortization 892,004 669,304 Total fixed assets, net $ 1,852,628 1,918,527 The Company recorded depreciation and amortization expense of $ 147,684 143,036

License Agreement, Related Part

License Agreement, Related Party	6 Months Ended
	Sep. 30, 2022
License Agreement Related Party
License Agreement, Related Party	Note 6 License Agreement, Related Party On April 30, 2019, the Company entered worldwide exclusive license with Drywave Technologies, Inc. (“Drywave”), a Company owned by Steve Howe. On the terms and conditions of the agreement, the Company received intellectual property rights to manufacture, use, and offer for sale all the products related to the patents and trademarks for dry hydrotherapy therapy technologies. The license fee to acquire the technology was $ 2,000,000 (a) $ 350,000 1,000 (b) $ 200,000 (c) $ 1,450,000 The Company made all the required payments as of March 31, 2021. After payment of the $2,000,000 License Fee and not later than April 30, 2020, the Company began paying to Drywave a royalty of 3% of Net Sales beginning May 1, 2020 and continuing for the longer of the period in which there are valid patent claims or ten years. The Company is performing on this agreement. As at September 30, 2022, the Company has recorded a royalty liability of $ 32,808 filing. The company recorded the original license fee as an intangible asset as of April 30, 2019 and is amortizing the asset over the expected useful life of the asset of 10 100,050 100,050

Lease Liability

Lease Liability	6 Months Ended
	Sep. 30, 2022
Lease Liability
Lease Liability	Note 7 Lease Liability On January 1, 2022, we adopted ASC Topic 842 – Leases. Under this new guidance, lessees are required to recognize assets and liabilities on the balance sheet for the rights and obligations created by all leases. As of September 30, 2022 and 2021 the company recorded its ROU lease liabilities of $ 135,462 0 Lessee accounting We determine if an arrangement is or contains a lease at inception. Our assessment is based on (1) whether the contract involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use of the asset throughout the period and (3) whether we have the right to direct the use of the asset. Leases are classified as either finance leases or operating leases. Under the guidance of ASC 842, operating leases are included in right-of-use assets, current lease liabilities, and noncurrent lease liabilities on our balance sheets. ROU assets and lease liabilities are recognized at commencement date based on the present value of the future minimum lease payments over the lease term. As most of our leases do not provide an implicit interest rate, we use our incremental borrowing rate based on the information available at transition date in determining the present value of future payments. The ROU asset includes any lease payments made but excludes lease incentives and initial direct costs incurred, if any. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Lease extensions Many leases have options to either extend or terminate the lease. In determining the lease term, we considered all available contract extensions that are reasonably certain of occurring. Operating leases The Company has three operating leases, each with different terms. Lease 1 entered into on July 23, 2020 is effective for 3 years and 1 month from the commencement date. The lease requires adjustment upon the annual commencement date with an increase to the monthly rent by 3%. Lease 2 entered into on February 24, 2021 is effective for 3 years and 1 month from the commencement date. The lease requires monthly increases until the monthly amount reaches $ 5,000 The following table summarizes balance sheet data related to leases at September 30, 2022 and September 30, 2021: Schedule of Balance Sheet Related To Leases September 30, 2022 September 30, 2021 Assets Operating lease right of use assets #1 $ 71,401 $ - Operating lease right of use assets #2 145,855 - Operating lease right of use assets #3 47,207 - Operating lease right of use assets Less accumulated depreciation (147,363 ) - Total operating lease right of use assets $ 117,098 $ - Liabilities Operating lease liability, current 101,465 - Operating lease liability, noncurrent 33,997 - Total lease liabilities 135,462 - Operating lease liability is presented net of lease payments. The Company is required to make monthly payments for each lease. During the fiscal year ended September 30, 2022, the Company paid $ 44,101 8,080

Notes Payable

Notes Payable	6 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Notes Payable	Note 8 Notes Payable The following are the various notes payable of the Company: Covid-19 PPP Loan During the year ended March 31, 2021, the Company entered into loans under the Paycheck Protection Program (“PPP”) sponsored by the U.S. Small Business Administration (SBA) providing for proceeds of $ 588,891 1.0 294,066 146,200 148,625 593,546 Senior Secured Notes In June 2021, the Company entered into a Senior Secured Note with Auctus Fund for $ 650,000 55,000 595,000 12 78,000 Any principal amount or interest on this note which is not paid when due shall bear interest at the rate of the lesser of (i) sixteen percent (16%) per annum and (ii) the maximum amount permitted by law from the due date thereof until the same is paid. On July 14, 2021, the principal amount of the note was increased by $ 25,000 675,000 Also pursuant to the agreement, in connection with the issuance of the note, the Company issued two common stock purchase warrants (separately, the “First Warrant” and the “Second Warrant” and together, the “Warrants”) to Auctus, each allowing Auctus to purchase an aggregate of 4,333,333 0.15 The total fair value of the warrants was estimated on the issue date at $ 513,827 Schedule of Fair Value of the Warrants June 24, 2022 Market price of common stock on date of issuance $ 0.30 Risk-free interest rate 0.48 % Expected dividend yield 0 Expected term (in years) 3 Expected volatility 199.6 % On or about November 22, 2021, the Company triggered an event of default under the Auctus Note and related documents which entitled Auctus, among other things, to accelerate the due date of the unpaid principal amount of, and all accrued and unpaid interest on, the Auctus Note. On February 17, 2022, Auctus and the Company executed a Waiver Letter which waived such defaults effective as of November 22, 2021. The note is secured by an Affidavit of Confession of Judgment and ranks senior over all existing and future indebtedness of the Borrower. Nonconvertible Notes – Related Party As of September 30, 2022, the Company has issued $ 1,994,655 1,852,735 141,920 Schedule of Nonconvertible Notes Related Party Interest Rate Issuance Date Maturity September 30, 2022 4.00 % 12/31/2018 12/31/2023 55,250 4.00 % 12/31/2018 12/31/2022 66,900 4.00 % 12/31/2018 12/31/2023 74,220 4.00 % 9/30/2019 9/29/2023 314,000 4.00 % 9/17/2019 9/16/2023 81,500 4.00 % 9/30/2019 9/29/2023 12,450 1.00 % 12/31/2020 12/30/2022 254,382 1.00 % 12/31/2020 12/30/2022 235,600 1.00 % 12/31/2020 12/30/2022 83,785 4.00 % 12/31/2020 12/31/2022 53,100 4.00 % 12/31/2020 12/31/2022 13,468 12.00 % 1/10/22 5/10/2023 750,000 1,994,655 Nonconvertible Notes As of September 30, 2022, the Company has issued $ 1,959,137 1,792,566 166,571 Schedule of Nonconvertible Notes Non Related Interest Rate Default Rate Issuance Date Maturity September 30, 2022 14 % N/A 8/1/18 1/31/22 $ 500,000 14.2 % 25 % 9/18/19 9/18/23 $ 23,347 14.2 % 25 % 10/9/19 10/9/23 $ 37,037 14 % Additional 2 % 10/30/19 10/29/21 $ 229,500 14 % Additional 2 % 12/31/19 12/31/20 $ 102,000 14 % N/A 2/5/20 2/5/21 $ 50,000 20 % Additional 2 % 2/25/20 2/25/2023 $ 220,000 20 % Additional 2 % 2/28/20 6/30/22 $ 104,000 14.2 % 25 % 3/10/20 3/10/24 $ 90,654 20 % Additional 2 % 4/24/20 4/23/21 $ 20,000 30 % Additional 2 % 10/29/20 2/28/21 $ 25,500 12 % Additional 2 % 10/30/20 11/1/21 $ 25,500 12 % Additional 2 % 10/30/20 11/1/21 $ 25,500 20 % N/A % 2/2/21 5/31/22 $ 45,000 15 % N/A % 4/1/21 3/31/24 $ 38,880 10 % N/A % 4/1/21 3/31/22 $ 100,000 N/A% N/A % 8/11/21 12/31/21 $ 322,219 $ 1,959,137 Convertible Notes – Related Party The Company has issued $ 29,970 4 2 Maturity Date 8 29,970 29,970 Convertible Notes As of September 30, 2022, the Company has issued $ 1,438,193 1,368,193 70,000 Schedule of Convertible Notes Interest Rate Conversion Rate Issuance Date Maturity September 30, 12 % $ 1.80 5/5/19 1/26/21 $ 102,000 12 % $ 1.80 7/10/19 7/9/21 $ 153,000 12 % $ 1.80 2/12/20 2/11/21 $ 102,000 8 % $ 0.22 3/9/21 3/8/22 $ 100,000 2 % $ 0.30 6/16/21 3/31/22 $ 250,000 10 % $ 0.30 6/22/21 6/21/22 $ 50,000 10 % $ 7.50 8/30/21 8/29/22 $ 150,000 10 % $ 7.50 8/31/21 8/30/22 $ 75,000 10 % $ - * 8/31/21 8/30/22 $ 50,000 10 % $ - * 9/15/21 9/14/22 $ 20,000 10 % $ - * 9/20/21 9/19/22 $ 10,000 10 % $ - * 9/22/21 9/21/22 $ 10,000 10 % $ - * 10/13/21 10/12/22 $ 50,000 10 % $ 7.50 10/18/21 10/17/22 $ 25,000 10 % $ 7.50 10/20/21 10/19/22 $ 20,000 10 % $ - * 10/28/21 10/27/22 $ 20,000 10 % $ - 12/27/21 12/26/22 $ 20,000 10 % $ - * 2/11/22 2/10/23 $ 10,000 10 % $ - 2/22/22 2/21/23 $ 5,000 8 % $ - * 5/05/22 11/5/23 $ 70,000 8 % $ - 5/17/22 5/11/23 $ 55,000 8 % $ - * 5/31/22 5/30/23 $ 33,750 10 % $ - * 8/31/22 8/30/23 $ 25,000 10 % $ - * 9/15/22 9/14/23 $ 25,000 adjustment $ 7,443 $ 1,438,193 * Upon commencement by the Company of a Qualified Financing, all of the outstanding principal and interest shall convert into that number of shares of New Round Stock, based upon a conversion price equal to the actual price per share of New Round Stock in the Qualified Financing. If not converted prior to the twelve-month anniversary of the issuance of the Notes, the Notes will be payable upon demand. Prepayment is not permitted prior to a payoff event. The Company evaluates these notes at commencement for beneficial conversion features and derivatives. As of September 30, 2022, the Company recorded a beneficial conversion feature on the convertible notes of $ 1,014,478 771,576

Shareholders_ Equity

Shareholders’ Equity	6 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Shareholders’ Equity	Note 9 Shareholders’ Equity Common Stock - 1,500,000,000 0.001 a. One non-cumulative vote for each share held of record on all matters submitted to a vote of the stockholders; b. To participate equally and to receive all such dividends as may be declared by the Board of Directors out of funds legally available; therefore, and c. To participate pro rata in any distribution of assets available for distribution upon liquidation. Stockholders have no pre-emptive rights to acquire additional shares of common stock or any other securities. Common shares are not subject to redemption and carry no subscription or conversion rights. Preferred Stock 10,000,00 150,000,000 The Company has not declared or paid any dividends or returned any capital to common stock shareholders as of September 30, 2022, and 2021.

Income Taxes

Income Taxes	6 Months Ended
	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Note 10 Income Taxes Income Tax Expense For the fiscal year ended September 30, 2022, the reconciliation between the income tax benefit computed by applying the statutory U.S. federal income tax rate to the pre-tax loss before income taxes, and total income tax expense recognized in the financial statements is the change in the valuation allowance. For the fiscal year ended September 30, 2020, and 2021, the Company did no NOL Carryforwards and Other Matters The Company files income tax returns in the U.S. federal jurisdiction and the state of Colorado. The Company’s federal and state tax years for the 2018 fiscal year and forward are subject to examination by taxing authorities. The Company did no

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 11 Commitments and Contingencies Off-Balance Sheet Arrangements - Leases - 200 The Company leases a warehouse facility of approximately 1,500 The Company has terminated the lease of approximately 4,500 square feet for intended the location of the new BodyStop™ located in the state of NY, and is relocating to a yet to be confirmed, more suitable location near the recently terminated location. Licenses 2 Legal Matters

Subsequent Events

Subsequent Events	6 Months Ended
	Sep. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 12 Subsequent Events None noted

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation
Principles of Consolidation	Principles of Consolidation Unaudited Interim Financial Information - The accompanying Consolidated Balance Sheet as of September 30, 2022 and 2021, the Consolidated Statements of Income for the three and six months ended September 30, 2022 and 2021, the Consolidated Statements of Changes in Stockholders Equity for the six months ended September 30, 2022 and 2021, and the Consolidated Statements of Cash Flows for the six month ended September 30, 2022 and 2021 are unaudited. These unaudited interim consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP). In our opinion, the unaudited interim consolidated financial statements include all adjustments of a normal recurring nature necessary for the fair presentation of our financial position as of September 30, 2022 and 2021, our results of operations for the three and six months ended September 30, 2022 and 2021, and our cash flows for the six months ended September 30, 2022 and 2021. The results of operations for the three and six months ended September 30, 2022 and 2021 are not necessarily indicative of the results to be expected for the year ending March 31, 2023. These unaudited interim consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2022 filed with the SEC on October 17, 2022. Prior period balance related to inventories has been reclassified to conform to the current year presentation.
Accounting Estimates	Accounting Estimates
Risks and Uncertainties	Risks and Uncertainties
Loss Per Common Share	Loss Per Common Share 231,505,146 224,227,107
Cash	Cash
Accounts Receivable	Accounts Receivable 54,251 66,950
Related Party Transactions	Related Party Transactions
Advance Payments on Purchases of Inventory, related party	Advance Payments on Purchases of Inventory, related party 0 40,000
Fixed Assets	Fixed Assets 241,854 169,230
Intangible Asset	Intangible Asset 10 650,150 500,075
Leases	Leases
License Payable, related party	License Payable, related party
Warranty Liability	Warranty Liability 5
Beneficial Conversion Features	Beneficial Conversion Features
Derivatives	Derivatives
Revenue	Revenue The Company derives its revenues primarily from the usage fees and sales of hydrotherapy massage beds and installation services. Revenues from sales are recognized when the products are sold and delivered to its customers and the usage fees are earned based on subscription or actual usage. Sales Taxes and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. Shipping and handling fees charged to customers are reported within revenue.
Income Taxes	Income Taxes The Company adopted section 740-10-25 of the FASB Accounting Standards Codification (“Section 740-10-25”). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Section 740-10-25 also provides guidance on de- recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carrybacks and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary. Management makes judgments as to the interpretation of the tax laws that might be challenged upon an audit and cause changes to previous estimates of tax liability. In addition, the Company operates within multiple taxing jurisdictions and is subject to audit in these jurisdictions. In management’s opinion, adequate provisions for income taxes have been made for all years. If actual taxable income by tax jurisdiction varies from estimates, additional allowances or reversals of reserves may be necessary.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair Value Measurements and Disclosures ● Level 1: Quoted prices for identical assets and liabilities in active markets; ● Level 2: Quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and ● Level 3: Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The carrying amounts of financial instruments including cash, accounts payable, warranty liability and notes payable approximated fair value based on Level 1 measurement as of September 30, and 2021 due to the relatively short maturity of the respective instruments.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements - In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments Implementation of this ASU had no material impact on the consolidated financial statements. In August 2020, the FASB issued ASU 2020-06 , Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity Derivatives and Hedging Derivatives and Hedging—Contracts in Entity’s Own Equity As of September 30, 2022, there were several new accounting pronouncements issued by the Financial Accounting Standards Board. Each of these pronouncements, as applicable, has been or will be adopted by the Company. Management does not believe the adoption of any of these accounting pronouncements has had or will have a material impact on the Company’s consolidated financial statements.

Fixed Assets (Tables)

Fixed Assets (Tables)	6 Months Ended
	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Schedule of Fixed Assets	The carrying basis and accumulated depreciation of fixed assets at September 30, 2022 and 2021 is as follows: Schedule of Fixed Assets Useful Lives September 30, 2022 September 30, 2021 Equipment in use 5 $ 394,620 $ 359,000 Vehicles and Trailers 5 60,266 60,266 Patent Costs 10 2,001,000 2,001,000 Building improvements 40 288,746 167,565 Less depreciation and amortization 892,004 669,304 Total fixed assets, net $ 1,852,628 1,918,527

Lease Liability (Tables)

Lease Liability (Tables)	6 Months Ended
	Sep. 30, 2022
Lease Liability
Schedule of Balance Sheet Related To Leases	The following table summarizes balance sheet data related to leases at September 30, 2022 and September 30, 2021: Schedule of Balance Sheet Related To Leases September 30, 2022 September 30, 2021 Assets Operating lease right of use assets #1 $ 71,401 $ - Operating lease right of use assets #2 145,855 - Operating lease right of use assets #3 47,207 - Operating lease right of use assets Less accumulated depreciation (147,363 ) - Total operating lease right of use assets $ 117,098 $ - Liabilities Operating lease liability, current 101,465 - Operating lease liability, noncurrent 33,997 - Total lease liabilities 135,462 -

Notes Payable (Tables)

Notes Payable (Tables)	6 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Schedule of Fair Value of the Warrants	Schedule of Fair Value of the Warrants June 24, 2022 Market price of common stock on date of issuance $ 0.30 Risk-free interest rate 0.48 % Expected dividend yield 0 Expected term (in years) 3 Expected volatility 199.6 %
Schedule of Nonconvertible Notes Related Party	Schedule of Nonconvertible Notes Related Party Interest Rate Issuance Date Maturity September 30, 2022 4.00 % 12/31/2018 12/31/2023 55,250 4.00 % 12/31/2018 12/31/2022 66,900 4.00 % 12/31/2018 12/31/2023 74,220 4.00 % 9/30/2019 9/29/2023 314,000 4.00 % 9/17/2019 9/16/2023 81,500 4.00 % 9/30/2019 9/29/2023 12,450 1.00 % 12/31/2020 12/30/2022 254,382 1.00 % 12/31/2020 12/30/2022 235,600 1.00 % 12/31/2020 12/30/2022 83,785 4.00 % 12/31/2020 12/31/2022 53,100 4.00 % 12/31/2020 12/31/2022 13,468 12.00 % 1/10/22 5/10/2023 750,000 1,994,655
Schedule of Nonconvertible Notes Non Related	Schedule of Nonconvertible Notes Non Related Interest Rate Default Rate Issuance Date Maturity September 30, 2022 14 % N/A 8/1/18 1/31/22 $ 500,000 14.2 % 25 % 9/18/19 9/18/23 $ 23,347 14.2 % 25 % 10/9/19 10/9/23 $ 37,037 14 % Additional 2 % 10/30/19 10/29/21 $ 229,500 14 % Additional 2 % 12/31/19 12/31/20 $ 102,000 14 % N/A 2/5/20 2/5/21 $ 50,000 20 % Additional 2 % 2/25/20 2/25/2023 $ 220,000 20 % Additional 2 % 2/28/20 6/30/22 $ 104,000 14.2 % 25 % 3/10/20 3/10/24 $ 90,654 20 % Additional 2 % 4/24/20 4/23/21 $ 20,000 30 % Additional 2 % 10/29/20 2/28/21 $ 25,500 12 % Additional 2 % 10/30/20 11/1/21 $ 25,500 12 % Additional 2 % 10/30/20 11/1/21 $ 25,500 20 % N/A % 2/2/21 5/31/22 $ 45,000 15 % N/A % 4/1/21 3/31/24 $ 38,880 10 % N/A % 4/1/21 3/31/22 $ 100,000 N/A% N/A % 8/11/21 12/31/21 $ 322,219 $ 1,959,137
Schedule of Convertible Notes	Schedule of Convertible Notes Interest Rate Conversion Rate Issuance Date Maturity September 30, 12 % $ 1.80 5/5/19 1/26/21 $ 102,000 12 % $ 1.80 7/10/19 7/9/21 $ 153,000 12 % $ 1.80 2/12/20 2/11/21 $ 102,000 8 % $ 0.22 3/9/21 3/8/22 $ 100,000 2 % $ 0.30 6/16/21 3/31/22 $ 250,000 10 % $ 0.30 6/22/21 6/21/22 $ 50,000 10 % $ 7.50 8/30/21 8/29/22 $ 150,000 10 % $ 7.50 8/31/21 8/30/22 $ 75,000 10 % $ - * 8/31/21 8/30/22 $ 50,000 10 % $ - * 9/15/21 9/14/22 $ 20,000 10 % $ - * 9/20/21 9/19/22 $ 10,000 10 % $ - * 9/22/21 9/21/22 $ 10,000 10 % $ - * 10/13/21 10/12/22 $ 50,000 10 % $ 7.50 10/18/21 10/17/22 $ 25,000 10 % $ 7.50 10/20/21 10/19/22 $ 20,000 10 % $ - * 10/28/21 10/27/22 $ 20,000 10 % $ - 12/27/21 12/26/22 $ 20,000 10 % $ - * 2/11/22 2/10/23 $ 10,000 10 % $ - 2/22/22 2/21/23 $ 5,000 8 % $ - * 5/05/22 11/5/23 $ 70,000 8 % $ - 5/17/22 5/11/23 $ 55,000 8 % $ - * 5/31/22 5/30/23 $ 33,750 10 % $ - * 8/31/22 8/30/23 $ 25,000 10 % $ - * 9/15/22 9/14/23 $ 25,000 adjustment $ 7,443 $ 1,438,193 * Upon commencement by the Company of a Qualified Financing, all of the outstanding principal and interest shall convert into that number of shares of New Round Stock, based upon a conversion price equal to the actual price per share of New Round Stock in the Qualified Financing. If not converted prior to the twelve-month anniversary of the issuance of the Notes, the Notes will be payable upon demand. Prepayment is not permitted prior to a payoff event.

Nature of Operations (Details N

Nature of Operations (Details Narrative) - USD ($)						6 Months Ended
	Apr. 06, 2021	Jan. 05, 2021	Apr. 17, 2020	Mar. 05, 2020	Jun. 25, 2019	Sep. 30, 2022	Mar. 31, 2022	Mar. 04, 2020
Entity incorporation, date of incorporation						Mar. 02, 2016
Entity incorporation, state or country code						NV
Common stock, shares authorized				100,000,000		1,500,000,000	1,500,000,000	75,000,000
Preferred stock authorized						150,000,000	150,000,000
Stockholders equity description				12.6374:1
Common stock, par value						$ 0.001	$ 0.001
Minimum [Member]
Common stock, shares authorized	100,000,000
Preferred stock authorized	10,000,000
Maximum [Member]
Common stock, shares authorized	1,500,000,000
Preferred stock authorized	150,000,000
Exchange Agreement [Member] | Mr. Amer Samad [Member] | Bed Therapies Inc [Member]
Stockholders equity description	the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to (i) increase the Company’s authorized shares of common stock from 100,000,000 to 1,500,000,000, (ii) increase the Company’s authorized shares of “blank check” preferred stock from 10,000,000 to 150,000,000, and (iii) effect a 1:15 forward stock split of the common stock.
Blank Check [Member]
Preferred stock authorized				10,000,000
Maksim Charniak [Member]
Equity method investment description						On June 25, 2019, Maksim Charniak, the Company’s then sole executive officer and director and the owner of 3,000,000 shares (pre- stock split) of the Company’s common stock, sold all his shares of common stock of the Company to Amer Samad, resulting in a change of control of the Company. As part of that transaction, Mr. Charniak resigned from all of his officer and director positions, and Mr. Samad was appointed as the Chief Executive Officer, President, Chief Financial Officer and Secretary of the Company, and was appointed to the Board of Directors of the Company. Mr. Samad also purchased 1,167,937 shares (pre-stock split) of the Company’s common stock in a series of private transactions, resulting in Mr. Samad owning 4,167,937 shares (pre-stock split) of the Company’s common stock, or approximately 95.6% of the issued and outstanding common stock of the Company.
Mr. Amer Samad [Member]
Stock issued during period shares stock splits					3,000,000
Ownership percentage					95.60%
Bed Therapies Inc [Member] | Exchange Agreement [Member]
Stock issued during period shares stock splits		1,269,665
Ownership percentage			100%
Stockholders equity description	Accordingly, the Company acquired 100% of Omnia Corp. in exchange for the issuance of 10,000,000 (not adjusted to reflect the Company’s 15:1 forward stock split on April 6, 2021) shares of the Company’s common stock and Omnia Corp. became the Company’s wholly owned subsidiary. As of the closing of the Acquisition (the “Closing”), Mr. Samad, resigned as an officer and director of the Company and agreed to cancel 52,656,888
Common stock, par value			$ 0.001
Debt conversion, converted instrument, amount			$ 539,000
Bed Therapies Inc [Member] | Exchange Agreement [Member] | Mr. Amer Samad [Member]
Cancellation of stock split			52,656,888

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details Narrative) - USD ($)		6 Months Ended
	Apr. 30, 2019	Sep. 30, 2022	Sep. 30, 2021
Accounting Policies [Abstract]
Number of anti-dilutive common stock		231,505,146	224,227,107
Accounts receivable		$ 54,251	$ 66,950
Advances on inventory		0	40,000
Accumulated depreciation		$ 241,854	169,230
Intangible asset expected life	10 years	10 years
Accumulated amortization		$ 650,150	$ 500,075
Monthly sales, percent		5%
Income tax descripition		The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Section 740-10-25 also provides guidance on de- recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.

Related Parties (Details Narrat

Related Parties (Details Narrative) - USD ($)	6 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Related Party Transaction [Line Items]
Royalty liability	$ 32,808
Contract Services Agreement [Member]
Related Party Transaction [Line Items]
Related party transaction, rate	10%
Royalty liability	$ 122,481
Consulting Agreement [Member]
Related Party Transaction [Line Items]
Related party transaction, description	The Company entered into a Consulting Agreement with Massagewave, Inc., owned and controlled by Steve Howe, to assist with business development and administrative activities. The agreement was entered into on May 1, 2018 and had required monthly payments of $15,000 per month.
Agreement expires date	Apr. 30, 2020
Consulting expense, related party	$ 91,000	$ 0
Consulting Agreement [Member] | Renew [Member]
Related Party Transaction [Line Items]
Agreement expires date	Apr. 30, 2023
Consulting Agreement [Member] | Massagewave Inc [Member]
Related Party Transaction [Line Items]
Payments of related party	$ 15,000

Schedule of Fixed Assets (Detai

Schedule of Fixed Assets (Details) - USD ($)	6 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Property, Plant and Equipment [Line Items]
Less depreciation and amortization	$ 892,004	$ 669,304
Total fixed assets, net	$ 1,852,628	1,918,527
Equipment [Member]
Property, Plant and Equipment [Line Items]
Useful lives	5 years
Fixed assets, gross	$ 394,620	359,000
Vehicles and Trailers [Member]
Property, Plant and Equipment [Line Items]
Useful lives	5 years
Fixed assets, gross	$ 60,266	60,266
Patent Costs [Member]
Property, Plant and Equipment [Line Items]
Useful lives	10 years
Fixed assets, gross	$ 2,001,000	2,001,000
Building Improvements [Member]
Property, Plant and Equipment [Line Items]
Useful lives	40 years
Fixed assets, gross	$ 288,746	$ 167,565

Fixed Assets (Details Narrative

Fixed Assets (Details Narrative) - USD ($)	6 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 147,684	$ 143,036

License Agreement, Related Pa_2

License Agreement, Related Party (Details Narrative) - USD ($)				6 Months Ended		12 Months Ended
	Mar. 02, 2020	Oct. 30, 2019	Apr. 30, 2019	Sep. 30, 2022	Sep. 30, 2021	Mar. 31, 2021
Defined Benefit Plan Disclosure [Line Items]
Payment to acquire technology	$ 1,450,000	$ 200,000	$ 350,000
Payment of escrow fee			$ 1,000
Royalty liability				$ 32,808
Finite-lived intangible asset, useful life			10 years	10 years
Amortization of intangible assets				$ 100,050	$ 100,050
Drywave Technologies, Inc. [Member]
Defined Benefit Plan Disclosure [Line Items]
Related party transaction, description of transaction						After payment of the $2,000,000 License Fee and not later than April 30, 2020, the Company began paying to Drywave a royalty of 3% of Net Sales beginning May 1, 2020 and continuing for the longer of the period in which there are valid patent claims or ten years. The Company is performing on this agreement. As at September 30, 2022, the Company has recorded a royalty liability of $32,808 and is on the consolidated balance sheet. No royalty has been paid as of the date of this
Drywave Technologies, Inc. [Member] | License Agreement [Member]
Defined Benefit Plan Disclosure [Line Items]
Accounts payable, related parties			$ 2,000,000

Schedule of Balance Sheet Relat

Schedule of Balance Sheet Related To Leases (Details) - USD ($)	Sep. 30, 2022	Mar. 31, 2022	Sep. 30, 2021
Assets
Less accumulated depreciation	$ (147,363)
Total operating lease right of use assets	117,098	$ 160,197
Liabilities
Operating lease liability, current	101,465	99,464
Operating lease liability, noncurrent	33,997	$ 80,099
Total lease liabilities	135,462
Operating Lease Right Of Use Assets One [Member]
Assets
Operating lease right of use assets	71,401
Operating Lease Right Of Use Assets Two [Member]
Assets
Operating lease right of use assets	145,855
Operating Lease Right Of Use Assets Three [Member]
Assets
Operating lease right of use assets	$ 47,207

Lease Liability (Details Narrat

Lease Liability (Details Narrative) - USD ($)	6 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Operating lease liabilities	$ 135,462
Lessee, operating lease, description	Our assessment is based on (1) whether the contract involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use of the asset throughout the period and (3) whether we have the right to direct the use of the asset. Leases are classified as either finance leases or operating leases.
Cash paid for lease	$ 44,101
Interest expense	$ 8,080
Lease One Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Lessee, operating lease, description	Lease 1 entered into on July 23, 2020 is effective for 3 years and 1 month from the commencement date. The lease requires adjustment upon the annual commencement date with an increase to the monthly rent by 3%. Lease 2 entered into on February 24, 2021 is effective for 3 years and 1 month from the commencement date. The lease requires monthly increases until the monthly amount reaches $5,000, then a 3% annual increase thereafter. Upon notice, the lease can be renewed for an additional two-year term at a rate 5% higher than set on schedule A of the lease. Lease 3 entered into on April 22, 2021 is effective for 3 years and 1 month from the commencement date. The lease may be renewed with renewal options to be determined at that time.
Lease Two Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Cash paid for lease	$ 5,000

Schedule of Fair Value of the W

Schedule of Fair Value of the Warrants (Details)	Jun. 24, 2022
Measurement Input Market Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Expected volatility	0.30
Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Expected volatility	0.48
Measurement Input, Expected Dividend Payment [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Expected volatility	0
Measurement Input, Expected Term [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Expected term (in years)	3 years
Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Expected volatility	199.6

Schedule of Nonconvertible Note

Schedule of Nonconvertible Notes Related Party (Details)	6 Months Ended
	Sep. 30, 2022 USD ($)
Nonconvertible Notes Related Party One [Member]
Short-Term Debt [Line Items]
Interest Rate	4%
Issuance Date	Dec. 31, 2018
Maturity	Dec. 31, 2023
Unsecured Debt	$ 55,250
Nonconvertible Notes Related Party Two [Member]
Short-Term Debt [Line Items]
Interest Rate	4%
Issuance Date	Dec. 31, 2018
Maturity	Dec. 31, 2022
Unsecured Debt	$ 66,900
Nonconvertible Notes Related Party Three [Member]
Short-Term Debt [Line Items]
Interest Rate	4%
Issuance Date	Dec. 31, 2018
Maturity	Dec. 31, 2023
Unsecured Debt	$ 74,220
Nonconvertible Notes Related Party Four [Member]
Short-Term Debt [Line Items]
Interest Rate	4%
Issuance Date	Sep. 30, 2019
Maturity	Sep. 29, 2023
Unsecured Debt	$ 314,000
Nonconvertible Notes Related Party Five [Member]
Short-Term Debt [Line Items]
Interest Rate	4%
Issuance Date	Sep. 17, 2019
Maturity	Sep. 16, 2023
Unsecured Debt	$ 81,500
Nonconvertible Notes Related Party Six [Member]
Short-Term Debt [Line Items]
Interest Rate	4%
Issuance Date	Sep. 30, 2019
Maturity	Sep. 29, 2023
Unsecured Debt	$ 12,450
Nonconvertible Notes Related Party Seven [Member]
Short-Term Debt [Line Items]
Interest Rate	1%
Issuance Date	Dec. 31, 2020
Maturity	Dec. 30, 2022
Unsecured Debt	$ 254,382
Nonconvertible Notes Related Party Eight [Member]
Short-Term Debt [Line Items]
Interest Rate	1%
Issuance Date	Dec. 31, 2020
Maturity	Dec. 30, 2022
Unsecured Debt	$ 235,600
Nonconvertible Notes Related Party Nine [Member]
Short-Term Debt [Line Items]
Interest Rate	1%
Issuance Date	Dec. 31, 2020
Maturity	Dec. 30, 2022
Unsecured Debt	$ 83,785
Nonconvertible Notes Related Party Ten [Member]
Short-Term Debt [Line Items]
Interest Rate	4%
Issuance Date	Dec. 31, 2020
Maturity	Dec. 31, 2022
Unsecured Debt	$ 53,100
Nonconvertible Notes Related Party Eleven [Member]
Short-Term Debt [Line Items]
Interest Rate	4%
Issuance Date	Dec. 31, 2020
Maturity	Dec. 31, 2022
Unsecured Debt	$ 13,468
Nonconvertible Notes Related Party Twelve [Member]
Short-Term Debt [Line Items]
Interest Rate	12%
Issuance Date	Jan. 10, 2022
Maturity	May 10, 2023
Unsecured Debt	$ 750,000
Nonconvertible Notes Related Party [Member]
Short-Term Debt [Line Items]
Unsecured Debt	$ 1,994,655

Schedule of Nonconvertible No_2

Schedule of Nonconvertible Notes Non Related (Details)	6 Months Ended
	Sep. 30, 2022 USD ($)
Nonconvertible Notes Non Related One [Member]
Short-Term Debt [Line Items]
Interest Rate	14%
Issuance Date	Aug. 01, 2018
Maturity	Jan. 31, 2022
Unsecured Notes Payable	$ 500,000
Nonconvertible Notes Non Related Two [Member]
Short-Term Debt [Line Items]
Interest Rate	14.20%
Issuance Date	Sep. 18, 2019
Maturity	Sep. 18, 2023
Unsecured Notes Payable	$ 23,347
Debt Instrument, Default Rate	25%
Nonconvertible Notes Non Related Three [Member]
Short-Term Debt [Line Items]
Interest Rate	14.20%
Issuance Date	Oct. 09, 2019
Maturity	Oct. 09, 2023
Unsecured Notes Payable	$ 37,037
Debt Instrument, Default Rate	25%
Nonconvertible Notes Non Related Four [Member]
Short-Term Debt [Line Items]
Interest Rate	14%
Issuance Date	Oct. 30, 2019
Maturity	Oct. 29, 2021
Unsecured Notes Payable	$ 229,500
Debt Instrument, Default Rate	2%
Nonconvertible Notes Non Related Five [Member]
Short-Term Debt [Line Items]
Interest Rate	14%
Issuance Date	Dec. 31, 2019
Maturity	Dec. 31, 2020
Unsecured Notes Payable	$ 102,000
Debt Instrument, Default Rate	2%
Nonconvertible Notes Non Related Six [Member]
Short-Term Debt [Line Items]
Interest Rate	14%
Issuance Date	Feb. 05, 2020
Maturity	Feb. 05, 2021
Unsecured Notes Payable	$ 50,000
Nonconvertible Notes Non Related Seven [Member]
Short-Term Debt [Line Items]
Interest Rate	20%
Issuance Date	Feb. 25, 2020
Maturity	Feb. 25, 2023
Unsecured Notes Payable	$ 220,000
Debt Instrument, Default Rate	2%
Nonconvertible Notes Non Related Eight [Member]
Short-Term Debt [Line Items]
Interest Rate	20%
Issuance Date	Feb. 28, 2020
Maturity	Jun. 30, 2022
Unsecured Notes Payable	$ 104,000
Debt Instrument, Default Rate	2%
Nonconvertible Notes Non Related Nine [Member]
Short-Term Debt [Line Items]
Interest Rate	14.20%
Issuance Date	Mar. 10, 2020
Maturity	Mar. 10, 2024
Unsecured Notes Payable	$ 90,654
Debt Instrument, Default Rate	25%
Nonconvertible Notes Non Related Ten [Member]
Short-Term Debt [Line Items]
Interest Rate	20%
Issuance Date	Apr. 24, 2020
Maturity	Apr. 23, 2021
Unsecured Notes Payable	$ 20,000
Debt Instrument, Default Rate	2%
Nonconvertible Notes Non Related Eleven [Member]
Short-Term Debt [Line Items]
Interest Rate	30%
Issuance Date	Oct. 29, 2020
Maturity	Feb. 28, 2021
Unsecured Notes Payable	$ 25,500
Debt Instrument, Default Rate	2%
Nonconvertible Notes Non Related Twelve [Member]
Short-Term Debt [Line Items]
Interest Rate	12%
Issuance Date	Oct. 30, 2020
Maturity	Nov. 01, 2021
Unsecured Notes Payable	$ 25,500
Debt Instrument, Default Rate	2%
Nonconvertible Notes Non Related Thirteen [Member]
Short-Term Debt [Line Items]
Interest Rate	12%
Issuance Date	Oct. 30, 2020
Maturity	Nov. 01, 2021
Unsecured Notes Payable	$ 25,500
Debt Instrument, Default Rate	2%
Nonconvertible Notes Non Related Fourteen [Member]
Short-Term Debt [Line Items]
Interest Rate	20%
Issuance Date	Feb. 02, 2021
Maturity	May 31, 2022
Unsecured Notes Payable	$ 45,000
Nonconvertible Notes Non Related Fifteen [Member]
Short-Term Debt [Line Items]
Interest Rate	15%
Issuance Date	Apr. 01, 2021
Maturity	Mar. 31, 2024
Unsecured Notes Payable	$ 38,880
Nonconvertible Notes Non Related Sixteen [Member]
Short-Term Debt [Line Items]
Interest Rate	10%
Issuance Date	Apr. 01, 2021
Maturity	Mar. 31, 2022
Unsecured Notes Payable	$ 100,000
Nonconvertible Notes Non Related Seventeen [Member]
Short-Term Debt [Line Items]
Issuance Date	Aug. 11, 2021
Maturity	Dec. 31, 2021
Unsecured Notes Payable	$ 322,219
Nonconvertible Notes Non Related [Member]
Short-Term Debt [Line Items]
Unsecured Notes Payable	$ 1,959,137

Schedule of Convertible Notes (

Schedule of Convertible Notes (Details)	6 Months Ended
	Sep. 30, 2022 USD ($) $ / shares
Convertible Notes One [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	12%
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 1.80
Issuance Date	May 05, 2019
Maturity	Jan. 26, 2021
Unsecured notes payable	$ 102,000
Convertible Notes Two [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	12%
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 1.80
Issuance Date	Jul. 10, 2019
Maturity	Jul. 09, 2021
Unsecured notes payable	$ 153,000
Convertible Notes Three [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	12%
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 1.80
Issuance Date	Feb. 12, 2020
Maturity	Feb. 11, 2021
Unsecured notes payable	$ 102,000
Convertible Notes Four [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	8%
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 0.22
Issuance Date	Mar. 09, 2021
Maturity	Mar. 08, 2022
Unsecured notes payable	$ 100,000
Convertible Notes Five [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	2%
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 0.30
Issuance Date	Jun. 16, 2021
Maturity	Mar. 31, 2022
Unsecured notes payable	$ 250,000
Convertible Notes Six [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 0.30
Issuance Date	Jun. 22, 2021
Maturity	Jun. 21, 2022
Unsecured notes payable	$ 50,000
Convertible Notes Seven [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 7.50
Issuance Date	Aug. 30, 2021
Maturity	Aug. 29, 2022
Unsecured notes payable	$ 150,000
Convertible Notes Eight [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 7.50
Issuance Date	Aug. 31, 2021
Maturity	Aug. 30, 2022
Unsecured notes payable	$ 75,000
Convertible Notes Nine [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares		[1]
Issuance Date	Aug. 31, 2021
Maturity	Aug. 30, 2022
Unsecured notes payable	$ 50,000
Convertible Notes Ten [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares		[1]
Issuance Date	Sep. 15, 2021
Maturity	Sep. 14, 2022
Unsecured notes payable	$ 20,000
Convertible Notes Eleven [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares		[1]
Issuance Date	Sep. 20, 2021
Maturity	Sep. 19, 2022
Unsecured notes payable	$ 10,000
Convertible Notes Twelve [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares		[1]
Issuance Date	Sep. 22, 2021
Maturity	Sep. 21, 2022
Unsecured notes payable	$ 10,000
Convertible Notes Thirteen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares		[1]
Issuance Date	Oct. 13, 2021
Maturity	Oct. 12, 2022
Unsecured notes payable	$ 50,000
Convertible Notes Fourteen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 7.50
Issuance Date	Oct. 18, 2021
Maturity	Oct. 17, 2022
Unsecured notes payable	$ 25,000
Convertible Notes Fifteen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 7.50
Issuance Date	Oct. 20, 2021
Maturity	Oct. 19, 2022
Unsecured notes payable	$ 20,000
Convertible Notes Sixteen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares		[1]
Issuance Date	Oct. 28, 2021
Maturity	Oct. 27, 2022
Unsecured notes payable	$ 20,000
Convertible Notes Seventeen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares		[1]
Issuance Date	Dec. 27, 2021
Maturity	Dec. 26, 2022
Unsecured notes payable	$ 20,000
Convertible Notes Eighteen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares		[1]
Issuance Date	Feb. 11, 2022
Maturity	Feb. 10, 2023
Unsecured notes payable	$ 10,000
Convertible Notes Nineteen [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares		[1]
Issuance Date	Feb. 22, 2022
Maturity	Feb. 21, 2023
Unsecured notes payable	$ 5,000
Convertible Notes Twenty [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	8%
Debt Instrument, Convertible, Conversion Price | $ / shares		[1]
Issuance Date	May 05, 2022
Maturity	Nov. 05, 2023
Unsecured notes payable	$ 70,000
Convertible Notes Twenty One [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	8%
Debt Instrument, Convertible, Conversion Price | $ / shares		[1]
Issuance Date	May 17, 2022
Maturity	May 11, 2023
Unsecured notes payable	$ 55,000
Convertible Notes Twenty Two [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	8%
Debt Instrument, Convertible, Conversion Price | $ / shares		[1]
Issuance Date	May 31, 2022
Maturity	May 30, 2023
Unsecured notes payable	$ 33,750
Convertible Notes Twenty Three [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares		[1]
Issuance Date	Aug. 31, 2022
Maturity	Aug. 30, 2023
Unsecured notes payable	$ 25,000
Convertible Notes Twenty Four [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	10%
Debt Instrument, Convertible, Conversion Price | $ / shares		[1]
Issuance Date	Sep. 15, 2022
Maturity	Sep. 14, 2023
Unsecured notes payable	$ 25,000
Convertible Notes Twenty Five [Member]
Short-Term Debt [Line Items]
Unsecured notes payable	7,443
Convertible Notes [Member]
Short-Term Debt [Line Items]
Unsecured notes payable	$ 1,438,193
[1]Upon commencement by the Company of a Qualified Financing, all of the outstanding principal and interest shall convert into that number of shares of New Round Stock, based upon a conversion price equal to the actual price per share of New Round Stock in the Qualified Financing. If not converted prior to the twelve-month anniversary of the issuance of the Notes, the Notes will be payable upon demand. Prepayment is not permitted prior to a payoff event.

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)			1 Months Ended					3 Months Ended		6 Months Ended		12 Months Ended
	Jul. 14, 2021	Jun. 24, 2021	Mar. 31, 2022	Oct. 31, 2021	Aug. 31, 2021	Jun. 30, 2021	May 31, 2021	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Mar. 31, 2022	Mar. 31, 2021	Dec. 30, 2020
Short-Term Debt [Line Items]
Interest rate, percentage													100%
Ppp loan forgiveness			$ 593,546	$ 148,625	$ 146,200		$ 294,066		$ 146,959		$ 443,873
Secured debt			$ 675,000									$ 675,000
Fair value adjustment of warrants		$ 513,827
Debt instrument, convertible, beneficial conversion feature										$ 1,014,478	771,576
Convertible Notes Payable [Member] | Related Party [Member]
Short-Term Debt [Line Items]
Debt instrument, interest rate, stated percentage								4%		4%
Notes payable related parties current and noncurrent								$ 29,970	$ 29,970	$ 29,970	$ 29,970
Debt instrument default interest rate								2%		2%
Convertible Notes Payable [Member] | Related Party [Member] | IPO [Member]
Short-Term Debt [Line Items]
Debt instrument, interest rate, stated percentage														8%
Investor [Member] | Convertible Notes Payable [Member]
Short-Term Debt [Line Items]
Convertible debt								$ 1,438,193		$ 1,438,193
Auctus Fund LLC [Member] | Warrant [Member] | Securities Purchase Agreement [Member]
Short-Term Debt [Line Items]
Stock issued during period shares new issues	4,333,333
Warrants exercise price	$ 0.15
Paycheck Protection Program Loan [Member]
Short-Term Debt [Line Items]
Proceeds from loan													$ 588,891
Senior Secured Note [Member]
Short-Term Debt [Line Items]
Principal amount	$ 25,000
Secured debt	$ 675,000
Senior Secured Note [Member] | Auctus Fund LLC [Member]
Short-Term Debt [Line Items]
Principal amount						$ 650,000
Discount amount						55,000
Proceeds from issuance of senior long-term debt						$ 595,000
Debt instrument, interest rate, stated percentage						12%
Interest expense												$ 78,000
Debt instrument, description												Any principal amount or interest on this note which is not paid when due shall bear interest at the rate of the lesser of (i) sixteen percent (16%) per annum and (ii) the maximum amount permitted by law from the due date thereof until the same is paid.
Nonconvertible Notes Related Party [Member]
Short-Term Debt [Line Items]
Unsecured notes payable								1,994,655		1,994,655
Nonconvertible Notes Related Party [Member] | Investor [Member]
Short-Term Debt [Line Items]
Unsecured notes payable								1,994,655		1,994,655
Unsecured Debt, Current								1,852,735		1,852,735
Unsecured long-term debt, noncurrent								141,920		141,920
Nonconvertible Notes [Member] | Investor [Member]
Short-Term Debt [Line Items]
Notes Payable								1,959,137		1,959,137
Notes payable current								1,792,566		1,792,566
Long term notes payable								166,571		166,571
Convertible Notes [Member]
Short-Term Debt [Line Items]
Unsecured notes payable								1,438,193		1,438,193
Convertible Notes [Member] | Investor [Member]
Short-Term Debt [Line Items]
Notes payable current								1,368,193		1,368,193
Long term notes payable								$ 70,000		$ 70,000

Shareholders_ Equity (Details N

Shareholders’ Equity (Details Narrative) - $ / shares	Sep. 30, 2022	Mar. 31, 2022	Apr. 06, 2021	Apr. 05, 2021	Mar. 05, 2020	Mar. 04, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized	1,500,000,000	1,500,000,000			100,000,000	75,000,000
Common stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	150,000,000	150,000,000
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized			150,000,000	10,000

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	6 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Current income tax expense benefit	$ 0	$ 0
Unrecognized tax benefits	$ 0	$ 0

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative)	6 Months Ended
	Sep. 30, 2022 ft²
Lessee, Lease, Description [Line Items]
Area of land	200
Master Facility License Agreement [Member]
Lessee, Lease, Description [Line Items]
Gross revenue percentage	2%
Warehouse Facility [Member]
Lessee, Lease, Description [Line Items]
Area of land	1,500
Body Stop [Member]
Lessee, Lease, Description [Line Items]
Area of land	4,500